Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Antiarrhythmic Therapy Can Perform Worse Than Placebo
Inferior performance of antiarrhythmic therapy compared with control group in the SCD-HeFT (Sudden Cardiac Death Heart Failure Trial) trial New York Heart Association functional class III patients (top) and the MUSTT (Multicenter Unsustained Ventricular Tachycardia Trial) trial (bottom). CI = confidence interval; EPG = electrophysiology-guided; ICD = implantable cardioverter-defibrillator.
|
